drugset / Trial / NCT00414765
Aldesleukin in Participants With Metastatic Renal Cell Carcinoma or Metastatic Melanoma
NaSingle-groupOpen-labelTreatment
Summary
This study evaluated the pharmacokinetics of aldesleukin in participants with metastatic renal cell cancer or metastatic melanoma.
Timeline
- Start
- 2008-09-03
- Primary completion
- 2010-03-28
- Completion
- 2010-03-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | aldesleukin | Protein / enzyme biologic | 600000 iu/kg | Intravenous |